The stock of Mereo BioPharma Group PLC (LON:MPH) is a huge mover today! The stock increased 5.95% or GBX 16 on November 3, hitting GBX 285. About 17,111 shares traded hands or 710.18% up from the average. Mereo BioPharma Group PLC (LON:MPH) has risen 6.00% since October 4, 2016 and is uptrending. It has outperformed by 4.79% the S&P500.
The move comes after 7 months positive chart setup for the GBX 184.06M company. It was reported on Nov, 3 by Barchart.com. We have GBX 524.40 PT which if reached, will make LON:MPH worth GBX 154.61M more.
More recent Mereo BioPharma Group PLC (LON:MPH) news were published by: Prnewswire.com which released: “Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m …” on July 29, 2015. Also Rttnews.com published the news titled: “Mereo BioPharma CFO And COO Richard Bungay to Leave in April 2017; stock down” on October 05, 2016. Businesswire.com‘s news article titled: “Osteoporosis Therapeutics Pipeline Report, H2 2015 – Research and Markets” with publication date: January 22, 2016 was also an interesting one.
Mereo BioPharma Group plc, formerly Mereo BioPharma Group Limited, is a biopharmaceutical firm focused on the acquisition and development of medicines that manages human health. The company has a market cap of 184.06 million GBP. The Firm is engaged in building a pipeline of medicines, focused on rare and specialist disease areas, through the acquisition of mid-stage development programs from biopharmaceutical companies. It currently has negative earnings. The Company’s initial mid-stage portfolio includes approximately three products that include BPS-804, BGS-649 and BCT-197.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.